Join to View Full Profile
1001 Sneath LnSan Bruno, CA 94066
Phone+1 650-615-6000
Fax+1 650-615-6015
Dr. Gordan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2011 - 2014- University of California (San Francisco)Residency, Internal Medicine, 2009 - 2011
Perelman School of Medicine at the University of PennsylvaniaClass of 2009
Certifications & Licensure
CA State Medical License 2011 - 2026
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Exploration of a Class of Aryl Imidazolyl Ureas As Potent Acid Ceramidase Inhibitors for the Treatment of Fibrotic Diseases.Richard Beresis, Vijaya Prathigudupu, Carson Cable, Amy Yu, Marc Adler
ACS Omega. 2025-08-12 - The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible.Nicholas O Stevers, Somang Kim, Jimmy Bo Yuan, Carter J Barger, Chibo Hong
Molecular Cell. 2025-06-19 - 1 citationsNeratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma.Ghassan K Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, Sarina A Piha-Paul, Joseph S Light
Liver Cancer. 2025-03-01
Journal Articles
- Overexpression-Mediated Activation of MET in the Golgi Promotes HER3/ERBB3 PhosphorylationJohn Gordan, MD, Nature
- Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic CholangiocarcinomaJohn D Gordan, Xin Chen, Clinical Cancer Research
Press Mentions
Drug Hobbles Deadly Liver Cancer by Stifling Protein ProductionJanuary 14th, 2019
OncLive® Hosts State of the Science Summit™: Gastrointestinal MalignanciesFebruary 22nd, 2018
John Gordan of UCSF Discusses His Work in Fibrolamellar CarcinomaNovember 13th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
